ReP USP - Resultado da busca

Artigo de periodico
Medullary astrocytes mediate irregular breathing patterns generation in chronic heart failure through purinergic P2X7 receptor signalling (2022)
Toledo, Camilo ; Jara, Esteban Díaz; Diaz, Hugo S. ; Schwarz, Karla G. ; Pereyra, Katherin V. ; Heras, Alexandra Las; Gallardo, Angélica Rios; Andrade, David C. ; Moreira, Thiago dos Santos ; Takakura, Ana Carolina ; Marcus, Noah J. ; Rio, Rodrigo Del
Source: EBioMedicine. Unidade: ICB
Subjects: FARMACOLOGIA, FISIOLOGIA, INSUFICIÊNCIA CARDÍACA, ASTRÓCITOS, ADENOSINA TRIFOSFATO, FISIOLOGIA RESPIRATÓRIA E CIRCULATÓRIA, RATOS, MOLÉCULA, MEMBRANA PLASMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOLEDO, Camilo et al. Medullary astrocytes mediate irregular breathing patterns generation in chronic heart failure through purinergic P2X7 receptor signalling. EBioMedicine, v. 80, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ebiom.2022.104044. Acesso em: 06 nov. 2024.
APA
Toledo, C., Jara, E. D., Diaz, H. S., Schwarz, K. G., Pereyra, K. V., Heras, A. L., et al. (2022). Medullary astrocytes mediate irregular breathing patterns generation in chronic heart failure through purinergic P2X7 receptor signalling. EBioMedicine, 80, 1-17. doi:10.1016/j.ebiom.2022.104044
NLM
Toledo C, Jara ED, Diaz HS, Schwarz KG, Pereyra KV, Heras AL, Gallardo AR, Andrade DC, Moreira T dos S, Takakura AC, Marcus NJ, Rio RD. Medullary astrocytes mediate irregular breathing patterns generation in chronic heart failure through purinergic P2X7 receptor signalling [Internet]. EBioMedicine. 2022 ; 80 1-17.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2022.104044
Vancouver
Toledo C, Jara ED, Diaz HS, Schwarz KG, Pereyra KV, Heras AL, Gallardo AR, Andrade DC, Moreira T dos S, Takakura AC, Marcus NJ, Rio RD. Medullary astrocytes mediate irregular breathing patterns generation in chronic heart failure through purinergic P2X7 receptor signalling [Internet]. EBioMedicine. 2022 ; 80 1-17.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2022.104044
Artigo de periodico-carta/editorial
New approaches for infective HPV detection, quantification and inactivation: preventing accidental virus transmission in medical settings (2021)
Boccardo, Enrique
Source: EBioMedicine. Unidade: ICB
Subjects: MICROBIOLOGIA, HPV, VÍRUS DE DNA, INFECÇÕES POR PAPILLOMAVIRUS, PAPILLOMAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCARDO, Enrique. New approaches for infective HPV detection, quantification and inactivation: preventing accidental virus transmission in medical settings. EBioMedicine. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.ebiom.2021.103222. Acesso em: 06 nov. 2024. , 2021
APA
Boccardo, E. (2021). New approaches for infective HPV detection, quantification and inactivation: preventing accidental virus transmission in medical settings. EBioMedicine. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.ebiom.2021.103222
NLM
Boccardo E. New approaches for infective HPV detection, quantification and inactivation: preventing accidental virus transmission in medical settings [Internet]. EBioMedicine. 2021 ; 64 2 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2021.103222
Vancouver
Boccardo E. New approaches for infective HPV detection, quantification and inactivation: preventing accidental virus transmission in medical settings [Internet]. EBioMedicine. 2021 ; 64 2 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2021.103222
Artigo de periodico
Novel and prevalent non-East Asian ALDH2 variants: implications for global susceptibility to aldehydes’ toxicity (2020)
Chen, Che-Hong ; Ferreira, Julio Cesar Batista ; Joshi, Amit Umesh ; Stevens, Matthew C. ; Li, Sin-Jin ; Hsu, Jade H.-M.; Maclean, Rory ; Ferreira, Nikolas Dresch; Cervantes, Pilar R.; Martinez, Diana D.; Barrientos, Fernando L.; Quintanares, Gibran Horemheb Rubio ; Rosen, Daria Mochly
Source: EBioMedicine. Unidade: ICB
Subjects: ANATOMIA, ÁLCOOL, ALDEÍDOS, MUTAÇÃO GENÉTICA, ESTUDOS DE COORTES, SEQUENCIAMENTO GENÉTICO, VARIAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHEN, Che-Hong et al. Novel and prevalent non-East Asian ALDH2 variants: implications for global susceptibility to aldehydes’ toxicity. EBioMedicine, v. 55, p. 11 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ebiom.2020.102753. Acesso em: 06 nov. 2024.
APA
Chen, C. -H., Ferreira, J. C. B., Joshi, A. U., Stevens, M. C., Li, S. -J., Hsu, J. H. -M., et al. (2020). Novel and prevalent non-East Asian ALDH2 variants: implications for global susceptibility to aldehydes’ toxicity. EBioMedicine, 55, 11 . doi:10.1016/j.ebiom.2020.102753
NLM
Chen C-H, Ferreira JCB, Joshi AU, Stevens MC, Li S-J, Hsu JH-M, Maclean R, Ferreira ND, Cervantes PR, Martinez DD, Barrientos FL, Quintanares GHR, Rosen DM. Novel and prevalent non-East Asian ALDH2 variants: implications for global susceptibility to aldehydes’ toxicity [Internet]. EBioMedicine. 2020 ; 55 11 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2020.102753
Vancouver
Chen C-H, Ferreira JCB, Joshi AU, Stevens MC, Li S-J, Hsu JH-M, Maclean R, Ferreira ND, Cervantes PR, Martinez DD, Barrientos FL, Quintanares GHR, Rosen DM. Novel and prevalent non-East Asian ALDH2 variants: implications for global susceptibility to aldehydes’ toxicity [Internet]. EBioMedicine. 2020 ; 55 11 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2020.102753
Artigo de periodico
In-depth characterization of congenital Zika syndrome in immunocompetent mice: antibody-dependent enhancement and an antiviral peptide therapy (2019)
Camargos, Vidyleison N. ; Foureaux, Giselle ; Medeiros, Daniel C.; Silveira, Vivian T. da ; Queiroz-Junior, Celso M.; Ana Luisa B. Matosinhos; Figueiredo, André F. A.; Sousa, Carla D. F.; Moreira, Thaiane P.; Queiroz, Victória F.; Dias, Ana Carolina F.; Karina T. O. Santana; Passos, Ingredy; Real, Ana Luíza C. V.; Silva, Ludmila C.; Mourão, Flávio A. G.; Wnuk, Natália T.; Oliveira, Milton A. P.; Macari, Soraia ; Silva, Tarcília; Garlet, Gustavo Pompermaier ; Jackman, Joshua A.; Soriani, Frederico M.; Moraes, Márcio F. D.; Mendes, Eduardo M. A. M.; Ribeiro, Fabíola M.; Costa, Guilherme M. J.; Teixeira, Antônio L.; Cho, Nam-Joon; Oliveira, Antônio C. P.; Teixeira, Mauro M.; Costa, Vivian V.; Souza, Danielle G.
Source: EBioMedicine. Unidade: FOB
Subjects: ZIKA VÍRUS, INFECÇÕES POR ARBOVIRUS, PEPTÍDEOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGOS, Vidyleison N. et al. In-depth characterization of congenital Zika syndrome in immunocompetent mice: antibody-dependent enhancement and an antiviral peptide therapy. EBioMedicine, v. 44, p. 516-529, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ebiom.2019.05.014. Acesso em: 06 nov. 2024.
APA
Camargos, V. N., Foureaux, G., Medeiros, D. C., Silveira, V. T. da, Queiroz-Junior, C. M., Ana Luisa B. Matosinhos,, et al. (2019). In-depth characterization of congenital Zika syndrome in immunocompetent mice: antibody-dependent enhancement and an antiviral peptide therapy. EBioMedicine, 44, 516-529. doi:10.1016/j.ebiom.2019.05.014
NLM
Camargos VN, Foureaux G, Medeiros DC, Silveira VT da, Queiroz-Junior CM, Ana Luisa B. Matosinhos, Figueiredo AFA, Sousa CDF, Moreira TP, Queiroz VF, Dias ACF, Karina T. O. Santana, Passos I, Real ALCV, Silva LC, Mourão FAG, Wnuk NT, Oliveira MAP, Macari S, Silva T, Garlet GP, Jackman JA, Soriani FM, Moraes MFD, Mendes EMAM, Ribeiro FM, Costa GMJ, Teixeira AL, Cho N-J, Oliveira ACP, Teixeira MM, Costa VV, Souza DG. In-depth characterization of congenital Zika syndrome in immunocompetent mice: antibody-dependent enhancement and an antiviral peptide therapy [Internet]. EBioMedicine. 2019 ; 44 516-529.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2019.05.014
Vancouver
Camargos VN, Foureaux G, Medeiros DC, Silveira VT da, Queiroz-Junior CM, Ana Luisa B. Matosinhos, Figueiredo AFA, Sousa CDF, Moreira TP, Queiroz VF, Dias ACF, Karina T. O. Santana, Passos I, Real ALCV, Silva LC, Mourão FAG, Wnuk NT, Oliveira MAP, Macari S, Silva T, Garlet GP, Jackman JA, Soriani FM, Moraes MFD, Mendes EMAM, Ribeiro FM, Costa GMJ, Teixeira AL, Cho N-J, Oliveira ACP, Teixeira MM, Costa VV, Souza DG. In-depth characterization of congenital Zika syndrome in immunocompetent mice: antibody-dependent enhancement and an antiviral peptide therapy [Internet]. EBioMedicine. 2019 ; 44 516-529.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2019.05.014
Artigo de periodico
Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma (2019)
Smalley, Inna; Kim, Eunjung; Li, Jiannong; Spence, Paige; Wyatt, Clayton; Eroglu, Zeynep; Sondak, Vernon K; Messina, Jane L; Babacan, Nalan Akgul ; Maria-Engler, Silvya Stuchi ; De Armas, Lesley; Williams, Sion L; Gatenby, Robert A; Chen, Y. Ann; Anderson, Alexander R. A; Smalley, Keiran S. M
Source: EBioMedicine. Unidade: FCF
Subjects: HETEROGENEIDADE, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMALLEY, Inna et al. Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma. EBioMedicine, v. 48, p. 178-190, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ebiom.2019.09.023. Acesso em: 06 nov. 2024.
APA
Smalley, I., Kim, E., Li, J., Spence, P., Wyatt, C., Eroglu, Z., et al. (2019). Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma. EBioMedicine, 48, 178-190. doi:10.1016/j.ebiom.2019.09.023
NLM
Smalley I, Kim E, Li J, Spence P, Wyatt C, Eroglu Z, Sondak VK, Messina JL, Babacan NA, Maria-Engler SS, De Armas L, Williams SL, Gatenby RA, Chen YA, Anderson ARA, Smalley KSM. Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma [Internet]. EBioMedicine. 2019 ; 48 178-190.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2019.09.023
Vancouver
Smalley I, Kim E, Li J, Spence P, Wyatt C, Eroglu Z, Sondak VK, Messina JL, Babacan NA, Maria-Engler SS, De Armas L, Williams SL, Gatenby RA, Chen YA, Anderson ARA, Smalley KSM. Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma [Internet]. EBioMedicine. 2019 ; 48 178-190.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2019.09.023
Artigo de periodico
Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis (2019)
Lago, Eloi M.; Silva, Marcos P.; Queiroz, Talita G.; Mazloum, Susana F.; Rodrigues, Vinícius C.; Carnaúba, Paulo U.; Pinto, Pedro L.; Rocha, Jefferson A.; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini ; Moraes, Josué de
Source: EBioMedicine. Unidade: IFSC
Subjects: SCHISTOSOMA, PLANEJAMENTO DE FÁRMACOS, CRISTALOGRAFIA FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAGO, Eloi M. et al. Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis. EBioMedicine, v. 43, p. 370-379, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ebiom.2019.04.029. Acesso em: 06 nov. 2024.
APA
Lago, E. M., Silva, M. P., Queiroz, T. G., Mazloum, S. F., Rodrigues, V. C., Carnaúba, P. U., et al. (2019). Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis. EBioMedicine, 43, 370-379. doi:10.1016/j.ebiom.2019.04.029
NLM
Lago EM, Silva MP, Queiroz TG, Mazloum SF, Rodrigues VC, Carnaúba PU, Pinto PL, Rocha JA, Ferreira LLG, Andricopulo AD, Moraes J de. Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis [Internet]. EBioMedicine. 2019 ; 43 370-379.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2019.04.029
Vancouver
Lago EM, Silva MP, Queiroz TG, Mazloum SF, Rodrigues VC, Carnaúba PU, Pinto PL, Rocha JA, Ferreira LLG, Andricopulo AD, Moraes J de. Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis [Internet]. EBioMedicine. 2019 ; 43 370-379.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2019.04.029
Artigo de periodico
Climate Change and Aedes Vectors: 21st Century Projections for Dengue Transmission in Europe (2016)
Liu-Helmersson, Jing; Qua, Mikkel; Wilder-Smith, Annelies; Stenlund, Hans; Ebi, Kristie; Massad, Eduardo ; Rocklöv, Joacim
Source: EBioMedicine. Unidade: FM
Subjects: DENGUE, VETORES, TEMPERATURA ATMOSFÉRICA, AEDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIU-HELMERSSON, Jing et al. Climate Change and Aedes Vectors: 21st Century Projections for Dengue Transmission in Europe. EBioMedicine, v. 7, p. 267-277, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ebiom.2016.03.046. Acesso em: 06 nov. 2024.
APA
Liu-Helmersson, J., Qua, M., Wilder-Smith, A., Stenlund, H., Ebi, K., Massad, E., & Rocklöv, J. (2016). Climate Change and Aedes Vectors: 21st Century Projections for Dengue Transmission in Europe. EBioMedicine, 7, 267-277. doi:10.1016/j.ebiom.2016.03.046
NLM
Liu-Helmersson J, Qua M, Wilder-Smith A, Stenlund H, Ebi K, Massad E, Rocklöv J. Climate Change and Aedes Vectors: 21st Century Projections for Dengue Transmission in Europe [Internet]. EBioMedicine. 2016 ; 7 267-277.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2016.03.046
Vancouver
Liu-Helmersson J, Qua M, Wilder-Smith A, Stenlund H, Ebi K, Massad E, Rocklöv J. Climate Change and Aedes Vectors: 21st Century Projections for Dengue Transmission in Europe [Internet]. EBioMedicine. 2016 ; 7 267-277.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ebiom.2016.03.046

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration